Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26 USD | +0.19% | -0.31% | +95.49% |
May. 02 | Dyne Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 30 | Morgan Stanley Starts Dyne Therapeutics With Overweight Rating, $40 Price Target | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 14.06M | Capitalization | 2.27B |
---|---|---|---|---|---|
Net income 2024 * | -259M | Net income 2025 * | -292M | EV / Sales 2024 * | - |
Net cash position 2024 * | 191M | Net cash position 2025 * | 301M | EV / Sales 2025 * | 140 x |
P/E ratio 2024 * |
-8.38
x | P/E ratio 2025 * |
-7.94
x | Employees | 143 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.45% |
1 day | +0.19% | ||
1 week | -0.31% | ||
Current month | +2.73% | ||
1 month | -3.09% | ||
3 months | +8.29% | ||
6 months | +198.85% | ||
Current year | +95.49% |
Managers | Title | Age | Since |
---|---|---|---|
Jason Rhodes
FOU | Founder | 54 | 17-11-30 |
Rick Scalzo
DFI | Director of Finance/CFO | 38 | 19-11-30 |
John Najim
CTO | Chief Tech/Sci/R&D Officer | 48 | 19-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Edward Hurwitz
BRD | Director/Board Member | 60 | 18-10-31 |
David Lubner
BRD | Director/Board Member | 60 | 20-02-29 |
Dirk Kersten
BRD | Director/Board Member | 49 | 18-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.02% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 26 | +0.19% | 538,840 |
24-05-09 | 25.95 | +1.01% | 1,008,522 |
24-05-08 | 25.69 | +0.16% | 464,282 |
24-05-07 | 25.65 | -2.29% | 496,815 |
24-05-06 | 26.25 | +0.65% | 646,639 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+95.49% | 2.27B | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- DYN Stock